Incidence and management of malignant digestive endocrine tumours in a well defined French population

Gut

Volumn 53, Issue 4, 2004, Pages 549-553

  Lepage, C ^a   Bouvier, A M ^a   Phelip, J M ^a   Hatem, C ^a   Vernet, C ^a   Faivre, J ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER STAGING; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ENDOCRINE TUMOR; FEMALE; FRANCE; HUMAN; INTESTINE RESECTION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SMALL INTESTINE CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; REGISTRIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1642342988     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.026401     Document Type: Article

References (22)

1. Solcia E. Histological typing of endocrine tumours. International histological classification of tumours, 2nd edn. Berlin: Springer-Verlag, 2000.
2. ICD-02. International classification of diseases for oncology. Geneva: World Health Organisation, 1992.
3. Sobin IH, Wittekind C. TNM Classification of Malignant Tumors Union Internationale Contre le Cancer and the American Joint Committee on Cancer, 5th edn. New York: John Wiley and Sons, 1997.
4. Hédelin G. RELSURV 1.0, a program for relative survival. Strasbourg: Presse Universitaire, 1995.
5. Watson RG, Johnston CF, O'Hare MM, et al. The frequency of gastrointestinal endocrine tumours in a well-defined population. Northern Ireland 1970-1985. Q J Med 1989;72:647-57.
6. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A 1976;84:322-30.
7. Newton JN, Swerdlow AJ, dos Santos Silva IM, et al. The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer 1994;70:939-42.
8. Ballantyne GH, Savoca PE, Flannery JT, et al. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 1992;69:2400.
9. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 2001;92:2204-10.
10. Quaedvlieg PF, Visser O, Lamers CB, et al. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001;12:1295-300.
11. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
12. Levi F, Randimbison L, Franceschi S, et al. Descriptive epidemiology of malignant carcinoids in the swiss canton of Vaud. Int J Cancer 1993;53:1036-7.
13. Moertel CG, Weiland LH, Nagorney DM, et al. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987;317:1699-701.
14. Corleto VD, Panzuto F, Falconi M, et al. Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2001;33:217-21.
15. Shebani KO, Souba WW, Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999;229:815-21.
16. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422-7.
17. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1502-22.
18. Moertel CG, Lefkopoulo M, Lipsitz S, et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-23.
19. Broder LE, Carter SK. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:108-18.
20. Burke AP, Thomas RM, Elsayed AM, et al. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997;79:1086-93.
21. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20:2633-42.
22. Faivre-Finn C, Bouvier A-M, Phelip J-M, et al. Colon cancer in France: evidence for improvement in management and survival. Gut 2002;51:60-4.